EA200500538A1 - Фармацевтическое средство для эндоназального применения при лечении болезней и нарушений нервной системы - Google Patents

Фармацевтическое средство для эндоназального применения при лечении болезней и нарушений нервной системы

Info

Publication number
EA200500538A1
EA200500538A1 EA200500538A EA200500538A EA200500538A1 EA 200500538 A1 EA200500538 A1 EA 200500538A1 EA 200500538 A EA200500538 A EA 200500538A EA 200500538 A EA200500538 A EA 200500538A EA 200500538 A1 EA200500538 A1 EA 200500538A1
Authority
EA
Eurasian Patent Office
Prior art keywords
nervous system
pharmaceutical agent
endasing
application
diseases
Prior art date
Application number
EA200500538A
Other languages
English (en)
Other versions
EA010692B1 (ru
Inventor
Наум Голдштейн
Роман Голдштейн
Original Assignee
Гольдштейн, Наум
Гольдштейн, Роман
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Гольдштейн, Наум, Гольдштейн, Роман filed Critical Гольдштейн, Наум
Publication of EA200500538A1 publication Critical patent/EA200500538A1/ru
Publication of EA010692B1 publication Critical patent/EA010692B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Otolaryngology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Изобретение касается фармацевтического средства, состоящего из одного или более стандартных активных веществ и/или из одного или более стандартных метаболитов, действующих на центральную нервную систему. Указанные активные вещества добавляются к веществам, действующим на слизистую оболочку носа для эндоназального применения.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA200500538A 2002-10-17 2003-10-11 Фармацевтическое средство для эндоназального применения при лечении болезней и нарушений центральной нервной системы EA010692B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10248601A DE10248601B4 (de) 2002-10-17 2002-10-17 Pharmazeutisches Mittel zur endonasalen Applikation bei der Behandlung von Krankheiten und Störungen des zentralen Nervensystems
PCT/DE2003/003376 WO2004037291A1 (de) 2002-10-17 2003-10-11 Pharmazeutisches mittel zur endonasalen applikation bei der behandlung von krankheiten und störungen des zentralen nervensystems

Publications (2)

Publication Number Publication Date
EA200500538A1 true EA200500538A1 (ru) 2005-12-29
EA010692B1 EA010692B1 (ru) 2008-10-30

Family

ID=32087002

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200500538A EA010692B1 (ru) 2002-10-17 2003-10-11 Фармацевтическое средство для эндоназального применения при лечении болезней и нарушений центральной нервной системы

Country Status (7)

Country Link
US (1) US20060153906A1 (ru)
EP (1) EP1562633A1 (ru)
AU (1) AU2003283188A1 (ru)
CA (1) CA2500090A1 (ru)
DE (1) DE10248601B4 (ru)
EA (1) EA010692B1 (ru)
WO (1) WO2004037291A1 (ru)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11201402938RA (en) * 2011-12-05 2014-07-30 Suda Ltd Oral spray formulations and methods for administration of sildenafil
DE102012009570A1 (de) 2012-05-09 2013-11-14 Naum Goldstein Komposition für nasale Anwendung
DE102012015248A1 (de) * 2012-08-05 2014-02-06 Naum Goldstein Verfahren zur Einbringung biologisch aktiver Substanzen ins Gehirn

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8918879D0 (en) * 1989-08-18 1989-09-27 Danbiosyst Uk Pharmaceutical compositions
GB9202464D0 (en) * 1992-02-05 1992-03-18 Danbiosyst Uk Composition for nasal administration
DE19514522C1 (de) * 1995-04-12 1996-06-13 Goldstein & Lewin Tech Gmbh Sauerstoffanionradikale enthaltende therapeutische Mittel und deren Verwendung zur Schmerzbehandlung
US5703073A (en) * 1995-04-19 1997-12-30 Nitromed, Inc. Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs
US6017963A (en) * 1995-11-14 2000-01-25 Euro-Celtique, S.A. Formulation for intranasal administration
DE19708643C2 (de) * 1997-02-20 1999-04-15 Goldstein & Lewin Tech Gmbh Verwendung von Sauerstoffanionradikalen und/oder deren Folge- und Abbauprodukte zur Behandlung von Morbus Parkinson
TWI223598B (en) * 1998-06-22 2004-11-11 Pfizer Ireland Pharmaceuticals An intranasal pharmaceutical composition for the treatment of male erectile dysfunction or female sexual disorders, an intranasal delivery system or device and sildenafil mesylate
US6200591B1 (en) * 1998-06-25 2001-03-13 Anwar A. Hussain Method of administration of sildenafil to produce instantaneous response for the treatment of erectile dysfunction
ITMI20021684A1 (it) * 2002-07-29 2004-01-29 Therapicon Srl Composizione farmaceutica di peptide nasale
RU2253461C1 (ru) * 2004-04-30 2005-06-10 Общество с ограниченной ответственностью "Паркинфарм" Фармацевтическая комбинация, оказывающая влияние на функционирование цнс, способ коррекции состояний, связанных с нарушениями функционирования цнс; фармацевтический набор; средство, способствующее проникновению через гематоэнцефалический барьер лекарственных субстанций и метаболитов; фармацевтическое средство для эндоназального применения

Also Published As

Publication number Publication date
EA010692B1 (ru) 2008-10-30
US20060153906A1 (en) 2006-07-13
DE10248601B4 (de) 2006-05-24
AU2003283188A1 (en) 2004-05-13
CA2500090A1 (en) 2004-05-06
WO2004037291A1 (de) 2004-05-06
DE10248601A1 (de) 2004-05-06
EP1562633A1 (de) 2005-08-17

Similar Documents

Publication Publication Date Title
CY1116464T1 (el) Θεραπεια συνδυασμου για τη θεραπευτικη αγωγη διαταραχων ανεπαρκειας πρωτεϊνης
AR026610A1 (es) Un derivado pirrolidinacetamida solo o en combinacion para tratamiento de desordenes del sistema nervioso central
PL371736A1 (en) Method for administering glp-1 molecules
CY1108932T1 (el) Ενωσεις 4-(ετεροκυκλυλ)-βενζολοσουλφοξιμινης για την θεραπευτικη αγωγη φλεγμονωδων ασθενειων
ATE408601T1 (de) Fredericamycin-derivate
NO20051966L (no) Nye pyrimidinamidderivater og anvendelse derav
TW200510375A (en) New compounds
NO20055173L (no) Farmasoytisk kombinasjonsblanding omfattende modafinil og et annet legemiddel
CY1110369T1 (el) Νεος συνεργιστικος συνδυασμος ο οποιος περιεχει ροφλουμιλαστη και φορμοτερολη
ATE478662T1 (de) Arzneilösungen enthaltend modafinilverbindungen
CY1106155T1 (el) Χρηση παραγωγων 3-βενζολοφαινυλοξικων οξεων για την αντιμετωπιση διαταραχων του αμφιβληστροειδους
EE200400005A (et) Tablett, mis sisaldab vähemalt kahte eristatavat segmenti ning selle kasutamine
CR7198A (es) Tableta que contiene cetirizina y pseudoefedrina
BRPI0511125A (pt) usos de ácido 5,6,7-triidroxieptanóico seus e análogos
CY1110368T1 (el) Συνεργιστικος συνδυασμος ο οποιος περιλαμβανει ροφλουμιλαστη και (r,r)-φορμοτερολη
EA200500538A1 (ru) Фармацевтическое средство для эндоназального применения при лечении болезней и нарушений нервной системы
EA200401454A1 (ru) Новая комбинация из обратимо действующих ингибиторов протонного насоса и используемых в терапии дыхательных путей лекарственных веществ, предназначенных для лечения респираторных заболеваний
BG105984A (bg) Използване на озанетант за приготвяне на лекарствени средства полезни за лечение на разстройства на настроението
SE0203817D0 (sv) New composition
ES2144857T3 (es) Utilizacion de derivados benzonaftalenicos para la fabricacion de medicamentos destinados para el tratamiento de las enfermedades del sistema nervioso.
DE60327249D1 (de) Anthranilsäureamide und ihre pharmazeutische verwendung
DE60322577D1 (de) Tablette enthaltend efletirizin und pseudoephedrin
NO20045344L (no) Kombinasjon for behandling av luftveisforstyrrelser

Legal Events

Date Code Title Description
PC4A Registration of transfer of a eurasian patent by assignment
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM BY KZ MD TJ TM

PC4A Registration of transfer of a eurasian patent by assignment
QB4A Registration of a licence in a contracting state
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AZ KG

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): RU